Evidence map›Paper›PMID 40822751›Full record

ArticleThe World Allergy Organization journal2025

A novel recognition of the major allergen, Hum j 1, from

Qiong Li, Yue Zhu, Fu-Xian Zhang, Ya-Li Cheng, Yong-Shi Yang, Ji-Fu Wei, Jin-Lyu Sun, Zhi-Qiang Xu

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiong LiDepartment of Pharmacy, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
Yue ZhuDepartment of Pharmacy, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
Fu-Xian ZhangDepartment of Pharmacy, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
Ya-Li ChengDepartment of Allergy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Yong-Shi YangDepartment of Allergy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Ji-Fu WeiDepartment of Pharmacy, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
Jin-Lyu SunDepartment of Allergy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhi-Qiang XuDepartment of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: During our work in isolating potential allergens from HJ pollen, we found a protein of around 10 kDa with obvious immunoglobulin E (IgE) binding activity than other fractions. This protein was then further identified by mass spectrometry, and its gene sequence was matched from our in-house built transcripts of HJ pollen based on the identified peptides. The gene was further confirmed by polymerase chain reaction (PCR) cloning, and the recombinant protein was prepared by Results: The 10 kDa protein with obvious IgE binding activity was finally purified from HJ pollen with a purity of 98%. The liquid chromatography-tandem mass spectrometry (LC-MS/MS) results identified 6 internal peptides, which covered 98.9% of the mature sequence of the 10 kDa protein with the N-terminal segment as DNCFENGMK. We surprisingly found that the 10 kDa protein was previously underrecognized Hum j 1 based on its limited sequence of only N-terminus. The sequence failed to be classified into any protein families by InterPro functional analysis, indicating the Hum j 1 could be the orphan protein. Both natural and recombinant Hum j 1 exhibited similar CD spectrum. The specific IgE binding rate against them was determined as 79% (11/14) in patients' serum with HJ pollen allergy by ELISA with a strong correlation in absorbance values (R Conclusion: These findings first provided solid evidence about the major allergen Hum j 1 in HJ pollen and resolved its unclear status. The defined sequence could enhance understanding of Hum j 1 properties and aid in producing high-quality recombinant allergens for diagnosing and treating HJ pollen allergy.

Indexed as

Conformational epitopesDisulfide bondsHum j 1Humulus japonicus pollen

Identifiers

PMID40822751
PMCPMC12355532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.